Can antimony, gadolinium, tin, and mycophenolic acid promote oxidative stress and immune dysregulation?

The claim is biologically credible: each agent has evidence for oxidative and/or immune effects, and both processes can plausibly feed into impaired self-tolerance and inflammatory signaling in the central nervous system. The strength and clinical meaning, however, differ substantially by chemical form and exposure context.

Exposure-specific effects

• Antimony—especially Sb(III) and antimony trioxide—impairs mitochondrial respiration, ATP production, membrane potential, and glutathione/thiol defenses, increasing ROS and oxidative macromolecular injury. Occupational studies also associate exposure with altered immunoglobulins, IL-2, IFN-γ, and monocyte-related markers.
• Gadolinium can increase ROS and activate inflammatory signaling mainly with free/inadequately chelated Gd³⁺ or certain agents in experimental systems. Macrophage TLR4/TLR7–NF-κB activation and NLRP3/ASC-dependent IL-1β release provide a mechanistic basis for immune activation. This should not be equated with a demonstrated chronic systemic immune disorder after routine GBCA use.
• Tin has strong experimental oxidative-stress evidence across inorganic compounds, nanoparticles, and organotins. Immune effects are most compelling for organotins—particularly tributyltin, dibutyltin, and triphenyltin—which can cause thymocyte apoptosis, lymphocyte impairment, altered antibody responses, and inflammatory cytokine signaling.
• Mycophenolic acid (MPA) has the clearest established clinical immune effect. By inhibiting IMPDH, it depletes guanosine nucleotides and suppresses activated T- and B-cell proliferation, causing cytopenias, reduced vaccine responses, and infection susceptibility. Intestinal and mouse models also show mitochondrial ROS-related epithelial injury.

Mechanistic relevance

• Excess ROS can reduce FoxP3+ regulatory-T-cell fitness and suppressive capacity, while oxidized self-proteins can create neoepitopes, promoting autoreactive T-cell responses and epitope spreading.
• ROS from NOX2 and damaged mitochondria can activate ERK/MAPK, NF-κB, and NLRP3 pathways in microglia, increasing IL-1β and IL-18. Dysregulated peripheral immunity may further compromise the blood–brain barrier and sustain microglial activation.

Bottom line

• These exposures can engage pathways relevant to immune-tolerance failure and neuroinflammation, but MPA causes direct, clinically established immunosuppression, whereas metal-related findings are predominantly compound-, dose-, and exposure-context dependent.